J.M. DiPirro, M.B. Kristal / Brain Research 1014 (2004) 22-33
33
[75] G.C. Rossi, G.W. Pasternak, R.J. Bodnar, A and y synergy between
the periaqueductal gray and the rostro-ventral medulla, Brain Res. 665
(1994) 85-93.
[76] G.C. Rossi, W. Su, L. Levanthal, H. Su, G.W. Pasternak, Antisense
mapping DOR-1 in mice: further support for y receptor subtypes,
Brain Res. 753 (1997) 176 - 179.
[77] R.B. Rothman, J.W. Holaday, F. Porecca, Allosteric coupling
among opioid receptors: evidence for an opioid receptor complex,
in: A. Herz, H. Akil, E.J. Simon (Eds.), Handbook of Experimental
Pharmacology: Opioids, I vol. 104, Springer-Verlag, Berlin, 1993,
pp. 217 - 237.
[78] H.W. Sander, A.R. Gintzler, Spinal cord mediation of the opioid
analgesia of pregnancy, Brain Res. 408 (1987) 389 - 393.
[79] J.A. Schriefer, Diethylstilbesterol- and pregnancy-induced changes in
rat neurointermediate lobe oxytocin, arginine vasopressin, methionine
enkephalin and dynorphin, Neuroendocrinology 54 (1991) 185 - 191.
[80] S. Siegel, N.J. Castellan Jr., Nonparametric Statistics for the Behav-
ioral Sciences, McGraw-Hill, New York, 1988.
[81] A.S. Smith, N.M. Lee, Opioid receptor interactions: local and nonlo-
cal, symmetric and symmetric, physical and functional, Life Sci. 73
(2003) 1873 - 1893.
[82] D.J. Smith, J.M. Perrotti, T. Crisp, M.E.Y. Cabral, J.T. Long, J.M.
Scalzitti, The mu receptor is responsible for descending pain inhibi-
tion originating in the periaqueductal gray region of the rat, Eur. J.
Pharmacol. 156 (1988) 47-54.
[83] I. Sora, M. Funada, G.R. Uhl, The A-opioid receptor is necessary for
[d-Pen2,d-Pen5]enkephalin-induced analgesia, Eur. J. Pharmacol. 324
(1997) R1 -R2.
[84] I. Sora, N. Takahashi, M. Funada, H. Ujike, R.S. Revay, D.M.
Donovan, L.L. Miner, G.R. Uhl, Opiate receptor knockout mice
define A receptor roles in endogenous nociceptive responses and
morphine-induced analgesia, Proc. Natl. Acad. Sci. U. S. A. 94
(1997) 1544 - 1549.
[85] R.L. Spencer, V.J. Hruby, T.F. Burks, Body temperature response
profiles for selective mu, delta and kappa opioid agonists in
restrained and unrestrained rats, J. Pharmacol. Exp. Ther. 246
(1988) 92 - 101.
[86] A.E. Takemori, P.S. Portoghese, Evidence for the interaction of mor-
phine with kappa and delta opioid receptors to induce analgesia in h-
Funaltrexamine-treated mice, J. Pharmacol. Exp. Ther. 243 (1987)
91 -94.
[87] J.A. Tarapacki, A.C. Thompson, M.B. Kristal, Gastric vagotomy
blocks opioid analgesia enhancement produced by placenta ingestion,
Physiol. Behav. 52 (1992) 179 - 182.
[88] J.A. Tarapacki, M. Piech, M.B. Kristal, Ingestion of amniotic fluid by
postpartum rats enhances morphine analgesia without liability to ma-
ternal behavior, Physiol. Behav. 57 (1995) 209 - 212.
[89] A.C. Thompson, M.B. Kristal, Opioid stimulation in the ventral teg-
mental area stimulates maternal behavior in rats, Brain Res. 743
(1996) 184 - 201.
[90] A.C. Thompson, J.M. DiPirro, C.D. Dickerson, M.B. Kristal, Amni-
otic-fluid ingestion inhibits contralateral circling after unilateral mor-
phine injection into the ventral tegmental area, Abstr.-Soc. Neurosci.
17 (1991) 1539.
[91] L.L. Tseng, R. Tang, R. Stackman, A. Camara, J.M. Fujimoto, Brain-
stem sites differentially sensitive to beta-endorphin and morphine for
analgesia and release of met-enkephalin in anesthetized rats, J. Phar-
macol. Exp. Ther. 253 (1990) 930 - 937.
[92] P.F. Von Voigtlander, R.A. Lewis, Analgesic and mechanistic evalu-
ation of spiradoline, a potent kappa opioid, J. Pharmacol. Exp. Ther.
246 (1988) 259 - 262.
[93] P.F. Von Voigtlander, R.A. Lahti, J.H. Ludens, U-50,488: a selective
and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol.
Exp. Ther. 224 (1983) 7-12.
[94] H.Q. Wang, J.P. Kampine, L.F. Tseng, Antisense oligodeoxynucleo-
tides to delta-opioid receptor messenger RNA selectively blocks the
antinociception induced by intracerebroventricularly administered
delta-, but not mu-, epsilon-, or kappa-opioid receptor agonists in
the mouse, Neuroscience 7 (1996) 445 - 452.
[95] L.R. Wardlaw, A.G. Frantz, Brain beta-endorphin during pregnancy,
parturition and the postpartum period, Endocrinology 113 (1983)
1664 - 1668.
[96] L.R. Watkins, E.P. Wiertelak, S.F. Maier, Kappa opiate receptors
mediate tail-shock induced antinociception at spinal levels, Brain
Res. 582 (1992) 1-9.
[97] G. Woolfe, A.D. MacDonald, The evaluation of analgesic action of
pethidine hydrochloride (Demerol), J. Pharmacol. Exp. Ther. 80
(1944) 300 - 307.
[98] L. Xin, E.B. Geller, M.W. Adler, Body temperature and analgesic
effects of selective mu and kappa opioid receptors microdialyzed into
rat brain, J. Pharmacol. Exp. Ther. 281 (1997) 499 - 507.
[99] G.A. Young, N. Khazan, Differential tolerance and cross-tolerance to
repeated daily injections of mu and kappa agonists in the rat, Neuro-
pharmacology 23 (1984) 505 - 509.
More intriguing information
1. The name is absent2. The name is absent
3. Non-causality in Bivariate Binary Panel Data
4. The name is absent
5. Convergence in TFP among Italian Regions - Panel Unit Roots with Heterogeneity and Cross Sectional Dependence
6. FDI Implications of Recent European Court of Justice Decision on Corporation Tax Matters
7. Equity Markets and Economic Development: What Do We Know
8. The name is absent
9. Alzheimer’s Disease and Herpes Simplex Encephalitis
10. The name is absent